Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research.
Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function.
Glycosylation defines the adhesive properties of proteins and cells. The immune system largely functions via glycan-protein interactions, which highlights the importance of glycans in physiology, pathogen recognition, cancer and autoimmune diseases.
Glycan molecules modulate many other processes important for cell and tissue differentiation, metabolic and gene regulation, protein activity, protein clearance, transport and more.
According to this study, over the next five years the Glycobiology (Diagnostics and Therapeutics) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Glycobiology (Diagnostics and Therapeutics) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Glycobiology (Diagnostics and Therapeutics) market by product type, application, key companies and key regions.
This study considers the Glycobiology (Diagnostics and Therapeutics) value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Diagnostics
Therapeutics
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Clinic
Hospital
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Biomarin Pharmaceutical Inc.
Glycomimetics
Glycan Biosciences Llc
Glycosensors And Diagnostics Llc
Glycotest Inc.
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Glycobiology (Diagnostics and Therapeutics) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Glycobiology (Diagnostics and Therapeutics) market by identifying its various subsegments.
Focuses on the key global Glycobiology (Diagnostics and Therapeutics) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Glycobiology (Diagnostics and Therapeutics) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Glycobiology (Diagnostics and Therapeutics) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
